EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Influence of Implant Macrodesign on Primary Stability Across Different Bone Density Models: A Comparative In Vitro Study

Lidija Veljkovic, Miljana Nedeljkovic, Jovana Milanovic, Aleksandra Arnaut, Momir Stevanovic, Gvozden Rosic, Dragica Selakovic, Nemanja Jovicic, Pavle Milanovic

Journal of Functional Biomaterials · 2026-11-03 · 17 (11) · 568

DOI: 10.3390/jfb17110568 ↗
AbstractBibliografische Angaben

Abstract

Background: Implant macrogeometry and bone density are major determinants of primary stability. This study aimed to evaluate primary stability across different implant macrodesigns and block models. Materials and Methods: A total of 153 implants were divided into Group 1 (AnyRidge), Group 2 (BlueDiamond RC), and Group 3 (BlueDiamond NC) (n = 51 each). Each implant was sequentially tested in synthetic D1–D4 bone models. Insertion torque values (ITV) and implant stability quotient (ISQ) were recorded. Results: In D1, ITV was highest in Group 1 (69.51 ± 1.50 Ncm), followed by Group 2 (53.82 ± 6.75 Ncm) and Group 3 (49.31 ± 7.00 Ncm) (p < 0.01, p < 0.001). In D4, ITV decreased to 34.71 ± 3.23, 19.90 ± 3.08, and 11.18 ± 2.14 Ncm, respectively (p < 0.001). D1 ISQ values were 84.53 ± 2.51, 72.08 ± 3.69, and 66.33 ± 2.63, respectively (p < 0.001). In D4, ISQ values were 60.29 ± 3.84, 52.86 ± 3.73, and 52.18 ± 2.48, respectively (p < 0.001); Groups 2 and 3 did not differ significantly. Conclusions: Implant macrodesign influences primary stability, with AnyRidge demonstrating the highest ITV and ISQ values in D1 as well as D4. Further clinical studies would be beneficial to support these findings.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →